Delivery Order SPE2DB22D3501-SPE2DB24FVB57
Award Date 3/28/24
Potential Completion Date 4/18/24
Potential Value $41K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $178,310.12, is for the supply of REVLIMID 5 MG CAPSULE 100S, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4564060034 REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $13,929.89 and a performance period through April 12, 2024. This delivery order is issued under Amerisourcebergen's pre-existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
- This is a $49,926.80 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 10 MG CAPSULE 28S. The contract has an ultimate completion date of August 20, 2024 and is a firm-fixed price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 10 MG CAPSULE 28S. This $55,719.56 contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This award is not associated with any set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $41,659.75 firm fixed price delivery order is for the supply of REVLIMID 10 MG CAPSULE 28S, a specialty drug product. The award has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a $103,758.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of REVLIMID 5 MG CAPSULE 100S. The award has an ultimate completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 20 MG CAPSULE 100S. The award, valued at $89,155.06, has an ultimate completion date of October 8, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range of medical commodities. This...
- This federal contract award is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $24,963.40 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024. The contract has an ultimate completion date of December 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...